Journal of Antimicrobial Chemotherapy (2001) 47, 163-170
© 2001 The British Society for Antimicrobial Chemotherapy
In vivo emergence of subpopulations expressing teicoplanin or vancomycin resistance phenotypes in a glycopeptide-susceptible, methicillin-resistant strain of Staphylococcus aureus
a Division of Infectious Diseases, University Hospitals of Geneva, CH-1211 Geneva 14; b Institute of Medical Microbiology, University of Zürich, Switzerland
Several reports indicate the emergence of subpopulations resistant to glycopeptides in some clinical isolates of Staphylococcus aureus. While the development of glycopeptide resistance in S. aureus is easily observed in vitro, the in vivo conditions promoting emergence of glycopeptide-resistant subpopulations are unknown. Using a rat model, subcutaneous implants were chronically infected with a methicillin-resistant strain of S. aureus, MRGR3, devoid of a significant (>10–7) glycopeptide-resistant subpopulation at 2 mg/L of either teicoplanin or vancomycin. After 3 weeks of infection in antibiotic-untreated animals, subpopulations emerged, growing on agar containing 10 mg/L of either glycopeptide. These subpopulations were detected in all tissue cage fluids containing >7 log cfu/mL at average frequencies of 4 x 10–5 and 2 x 10–5 on teicoplanin- and vancomycin-containing agar, respectively. While teicoplanin MICs increased two- to 16-fold, vancomycin MICs increased by less than two-fold. Population analysis and survival kinetic studies of three teicoplanin-selected subclones indicated that transfer from solid to liquid medium conditions decreased expression of teicoplanin resistance in the bacterial population. In Mueller–Hinton broth, >90% of cells remained fully resistant to antibiotic, but did not grow in the presence of teicoplanin for an initial period of at least 6 h. All three teicoplanin-resistant subclones expressed stable teicoplanin resistance with slight cross-resistance to vancomycin after a few transfers on teicoplanin-supplemented agar. These data suggest that some in vivo conditions may lead to selection of S. aureus subpopulations exhibiting decreased glycopeptide susceptibility and growing in the presence of otherwise inhibitory concentrations of these antimicrobial agents.
* Corresponding author. Tel: +41-22-372-9826; Fax: +41-22-372-9830; E-mail: pierre.vaudaux{at}hcuge.ch
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Renzoni, W. L. Kelley, C. Barras, A. Monod, E. Huggler, P. Francois, J. Schrenzel, R. Studer, P. Vaudaux, and D. P. Lew Identification by Genomic and Genetic Analysis of Two New Genes Playing a Key Role in Intermediate Glycopeptide Resistance in Staphylococcus aureus Antimicrob. Agents Chemother., March 1, 2009; 53(3): 903 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Amiali, M. R. Mulvey, B. Berger-Bachi, J. Sedman, A. E. Simor, and A. A. Ismail Evaluation of Fourier transform infrared spectroscopy for the rapid identification of glycopeptide-intermediate Staphylococcus aureus J. Antimicrob. Chemother., January 1, 2008; 61(1): 95 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Goldstein The potential clinical impact of low-level antibiotic resistance in Staphylococcus aureus J. Antimicrob. Chemother., January 1, 2007; 59(1): 1 - 4. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Renzoni, C. Barras, P. Francois, Y. Charbonnier, E. Huggler, C. Garzoni, W. L. Kelley, P. Majcherczyk, J. Schrenzel, D. P. Lew, et al. Transcriptomic and Functional Analysis of an Autolysis-Deficient, Teicoplanin-Resistant Derivative of Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother., September 1, 2006; 50(9): 3048 - 3061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. McCallum, H. Karauzum, R. Getzmann, M. Bischoff, P. Majcherczyk, B. Berger-Bachi, and R. Landmann In Vivo Survival of Teicoplanin-Resistant Staphylococcus aureus and Fitness Cost of Teicoplanin Resistance. Antimicrob. Agents Chemother., July 1, 2006; 50(7): 2352 - 2360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Vaudaux, A. Gjinovci, M. Bento, D. Li, J. Schrenzel, and D. P. Lew Intensive Therapy with Ceftobiprole Medocaril of Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus Antimicrob. Agents Chemother., September 1, 2005; 49(9): 3789 - 3793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Renzoni, P. Francois, D. Li, W. L. Kelley, D. P. Lew, P. Vaudaux, and J. Schrenzel Modulation of Fibronectin Adhesins and Other Virulence Factors in a Teicoplanin-Resistant Derivative of Methicillin-Resistant Staphylococcus aureus Antimicrob. Agents Chemother., August 1, 2004; 48(8): 2958 - 2965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Isnansetyo and Y. Kamei MC21-A, a Bactericidal Antibiotic Produced by a New Marine Bacterium, Pseudoalteromonas phenolica sp. nov. O-BC30T, against Methicillin-Resistant Staphylococcus aureus Antimicrob. Agents Chemother., February 1, 2003; 47(2): 480 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Schaaff, A. Reipert, and G. Bierbaum An Elevated Mutation Frequency Favors Development of Vancomycin Resistance in Staphylococcus aureus Antimicrob. Agents Chemother., November 1, 2002; 46(11): 3540 - 3548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Mongodin, O. Bajolet, J. Cutrona, N. Bonnet, F. Dupuit, E. Puchelle, and S. d. Bentzmann Fibronectin-Binding Proteins of Staphylococcus aureus Are Involved in Adherence to Human Airway Epithelium Infect. Immun., February 1, 2002; 70(2): 620 - 630. [Abstract] [Full Text] [PDF]
|
|